Bringing Pharma's AI-Based Molecule Discovery to Beauty and Wellness
A Game-Changer For
Thinning Hair.
Aging Skin.
Nutrition.
Total Wellness.
Innovation has been stagnant in beauty and wellness for decades.
Across hair, skin, and body wellness, genuine innovation and discovery has been avoided in favor of less challenging programs to retest and reformulate legacy ingredients.
Revela is a molecular discovery scalable platform
We leverage our molecular discovery pipeline to drive molecule and biological modality development for the most pressing visible (and invisible) challenges of wellness.
Raising the bar for expectations in consumer health & wellness
To achieve our mission, we use the same cutting-edge bioengineering and advanced AI techniques used to develop new medicines and cancer therapeutics and apply them to discover new molecules that directly target the issues impacting millions of people every day.
Never settle for good enough. We don't.
It's 2023. We have supercomputers in our pockets and technologies to edit entire genomes, yet consumers are still forced to accept the same ingredients their grandparents had, and continue to experience the same underwhelming results.
The products using our breakthrough molecules demonstrate safe and superior clinical efficacy as compared to what's currently on the market. Rather than rebranding what is already available, we reinvent what just isn't cutting it for consumers.
200+
Molecules Patent Pending
> 1B
Screenable Molecules
> 25K
Molecules Screened / Second
Bridging Molecule Discovery and Beauty & Wellness
We explore the universe of existing and potential molecules with our multi-layered technology platform
Developing Biological Models
Advanced Biological Models
Assay Development
Synthetic Biology
Generating Data
Robotic Phenotypic Screening
Omic Sequencing
Medicinal Chemistry
AI Molecule Screening & Optimization
In silico Molecular Screening
Deep Learning
Computational Biology
Lead Validation & Safety Testing
In vitro Efficacy Validation
Safety & Toxicity Screening
Ex vivo & Clinical Testing
Product Development
Analytical Chemistry
Formulation
Developing Biological Models
Advanced Biological Models
Assay Development
Synthetic Biology
Generating Data
Robotic Phenotypic Screening
Omic Sequencing
Medicinal Chemistry
AI Molecule Screening & Optimization
In silico Molecular Screening
Deep Learning
Computational Biology
Lead Validation & Safety Testing
In vitro Efficacy Validation
Safety & Toxicity Screening
Ex vivo & Clinical Testing
Product Development
Analytical Chemistry
Formulation
A Cross-Disciplinary Team of Engineers, Biologists, and Computer Scientists
Our team have backgrounds in synthetic biology, cancer therapeutics, chemo-genomics, small-molecule synthesis and discovery. Are you a passionate scientist looking for something different? Chat with us.
Evan Zhao, PhD
CEO
Former Schmidt Science Fellow. Synthetic biologist and chemical engineer. Evan received his B.S. in Chemical Engineering from Caltech and Ph.D. in Chemical Engineering from Princeton where he pioneered the use of optogenetics in metabolic engineering and protein therapeutics. Evan is the lead author of numerous high-impact publications in Nature, Nature Biotechnology, Nature Chemical Biology, Nature Communications, and more.
David Zhang, PhD
CSO
Immunologist and bioengineer. David Received his B.S. from McGill University, M.A.Sc from the University of Toronto, and Ph.D from Harvard University, where he developed next-generation cancer therapy technologies. He is an author or inventor on several high profile publications and patents, and has licensed his technologies to clinical-stage biopharma company.
Avinash Boppana
CTO
Computer scientist and expert in computational methods for molecule discovery and systems biology. Avi received his B.S.E from Princeton University where he created novel algorithms for genomics-informed therapeutic development. He has published in top journals including Nature Cell Biology, and has previous experience at Harvard Medical School and the NIH.
Evelyn Chen
CPO
Serial entrepreneur. Influencer. Evelyn received her M.S. in Biomedical Engineering from Columbia University and brings with her years of experience in the consumer goods industry.
Enzo Benfanti
Product Manager
Bridging the bench and the bottle. Enzo received his B.S. in Chemical Engineering from the University at Buffalo and his M.Eng in Chemical Engineering from Columbia University. He brings with him extensive experience in process chemistry and product development.
Connor Coley, PhD
Scientific Co-Founder
Henri Slezynger (1957) Career Development Assistant Professor at Massachusetts Institute of Technology and Forbes' 30 Under 30. Connor is a renowned expert in computational chemical engineering, where he and his group develop methods at the frontier of computer-aided chemical discovery and synthesis. He was awarded the NSF Career Award and is also a Schmidt AI2050 Early Career Fellow.
Il Makiage parent Oddity buys biotech startup Revela to design new molecules for beauty products
“With this acquisition, we are using biologics to bring game-changing, science-backed beauty and wellness products to the market and to our users. This is our DNA, we are not here to do more of the same but to build something new.”
Why the "Biotech" Boom Has Potential to Spur Real Change in the Beauty Industry
Beauty consumers are constantly searching for products that deliver on their marketing promises. But for all the advances beauty innovation is capable of from a formulation perspective, there are some limits to what is possible by cosmetic chemists in a lab.
Keep reading.
ODDITY ‘is transforming the beauty and wellness industry,’ CFO says
Today, we're harnessing that power and unleashing it for beauty and wellness indications. Revela is the leading biotech in the industry, and they are a pioneer in using AI for ingredient discovery, something we're really excited about.
Intel Ignite Selects 10 Leading-Edge Companies for First Startup Growth Program in the US
"Each of the startups selected for the Boston cohort is unique and disruptive. From quantum to AI to nano, these startups are building and innovating for the future, and they are pushing the envelope of what it means to create impact in deep tech."
Keep reading.
More Precious Than Gold: How a New Ingredient Is Redefining Hair Loss Treatment For Good
“In this whole space, there hasn’t been a lot of innovation for the last thirty years,” says Zhao. “It’s too bad because ingredient and chemical discovery over the last thirty years has exploded—our capabilities are ten thousand times better than what they were before.”
Continue reading.
Meet the AI-Discovered Skin-Care Ingredient, Fibroquin
Who would even know where to begin finding the next "notable contender" in the antiaging skin-care space? In the case of the latest ingredient, Fibroquin, it turns out that the answer is downright robotic (wink, wink)
Continue reading.
